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patients presenting a partial and complete response, 
respectively.  Mean time to best measured response was 
15.16 months  (range 2-58). Thirteen patients were alive, 
with a local control rate of  79%. Mean time to local 
progression was 5 months (range 3-7). New treatment 
with Cyberknife R and exenteratio after local progression 
were performed in 1 patient each. Fourteen patients 
reported symptomatic lesions, 5 and 3 patients had 
reduced visual field or impaired visual acuity before 
treatment, respectively. Overall, three patients reported 
improvement of symptoms after treatment; One patient 
reported partial recovery of visual acuity, the second 
reported pain decrease and reduced eye tearing , and the 
third reported improvement in visual field and reduced 
exophthalmus. About dosimetric data, mean PTV dose 
coverage was 97,2% (range 93,5-99,7). Mean maximum 
dose (Dmax) to eye globe, optic nerve, optic chiasm and 
lens was 2380.8 cGy (range 290-3921), 1982,82 cGy 
(range 777,3-2897,8), 713,14 cGy (range 219,5-2273) and 
867,9 cGy (range 38-3118,5). Four patients presented 
acute toxicity, defined as occurring within three months 
after the end of treatment (2 conjunctivitis,2 transitory 




In the current retrospective series, data demonstrated 
that CyberknifeR robotic stereotactic radiotherapy is a 
feasible and tolerable approach for intraorbital lesions, 
and should be considered in clinical practice. 
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Purpose or Objective  
Breast cancer is a common pathology in which <10% of 
cases at the moment of diagnosis are considered to be 
locally advanced. In patients with locally advanced breast 
cancer who have deterioration in overall condition, with 
local growth and secondary bleeding that are not 
subsidiary to surgery or other systemic therapies, 
superficial radiotherapy may be considered as an option 
in the treatment of these patients 
Objectives: It is described a number of cases with 
patients with locally advanced breast cancer with 
secondary bleeding who were treated with superficial 
radiotherapy for haemostatic purposes 
Material and Methods  
For a period from May 2016 to August 2017, 6 patients 
with locally advanced breast cancer who did not respond 
to systemic treatment or due to the disease or 
comorbidities associated were not candidates for that, 
who presented tumour growth with secondary bleeding 
and they were not subsidiaries of surgery. Superficial 
radiotherapy were administrated by a low energy X-Ray 
machine, with a total dose of 50 - 60Gy, divided in 1-2 
fractions per week. The haemostatic effect was value at 
the end of treatment. 
Results  
The average age was 73 years, most patients presented a 
grade 2 functional status (ECOG2). At the end of 
treatment, was objected a decrease of > o = 25% in tumor 
size and absence of bleeding was observed. 
Conclusion  
Surface radiotherapy is a treatment modality that should 
be taken into account in patients with breast cancer who 
present bleeding as a consequence of local tumor growth, 
given that this is a treatment comfortable for the 
patient, non invasive and increases the quality of 
patient’s life.  
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Purpose or Objective  
Spinal stereotactic radiosurgery (SSRS) is commonly being 
adopted in patients with spinal metastasis recently as it 
could provide dose escalation for durable tumor control 
with sparing of nearby organs at risk. However, there is 
no solid evidence about the optimal treatment schedule 
and no comprehensive understanding of the adverse 
events. In this study, we sought to compare two most 
widely used SSRS schemes (single fraction versus three 
fractions) in patients with spinal metastasis who did not 
previously undergo radiation treatment at the site of 
the SSRS and tried to evaluate the toxicity profile as well 
as predictive factors regarding outcomes and the risk of 
complications after SSRS. 
 
 
